Tonbo Imaging

Scailyte is a TechBio company leveraging multi-omics data and artificial intelligence to enable precision medicine, with a focus on autoimmune diseases. The company's ScaiVision platform employs a proprietary Supervised Representation Learning method that identifies complex molecular patterns associated with clinical outcomes without needing pre-defined cell types or clustering, enabling discovery of novel biological signals at unprecedented resolution and sensitivity. Scailyte is building what it describes as the world's deepest Autoimmune Foundation Model, anchored by single-cell and spatial omics data matched with longitudinal clinical outcomes, using deep generative and single-cell foundation models trained on vast amounts of patient-derived data for predictive disease modeling and patient endotyping at scale. The company's IBD Flagship Program is anchored by the Swiss IBD Cohort of over 4,000 patients with 15-plus years of longitudinal data and 40,000-plus samples, complemented by a single-cell omics IBD Atlas of 6 million profiles across 500-plus patients. Scailyte offers pharma partnerships in asset de-risking and trial stratification, target discovery and combination positioning, and precision diagnostics with companion biomarker assays. Founded in 2017 and headquartered in Basel, Switzerland, Scailyte has raised $20.3 million in Series A funding from investors including Zurcher Kantonalbank, Swisscom Ventures, Verve Ventures, Mirabaud, and HEMEX.

Security & Surveillance Technology > PIDAS > Imaging System,

Military Tech > Non Combat Systems > C4ISR > Surveillance & Reconnaissance > Imaging > Electro Optics

College Wise > BITS Pilani